The company obtained a credit facility of $15 million from Hercules. It will mature in 38 to 41 months. Baxano also entered into a $7 million common stock purchase agreement with Lincoln Park.
Baxano Surgical’s spine technology focuses on treating degenerative conditions of the lumbar spine.
More Articles on Devices:
Mazor Robotics Fills Renaissance Order From Singapore Distribution Parner
Smith & Nephew Acquires Brazilian Wound Care Company
Amedica Pens Manufacturing Deal with Kyocera Ceramics for Spine Devices
